The company employs around 280 people at its plant in Montrose and an announcement that 130 jobs were to go at a similar premises across the Irish Sea, had sparked fears for the security of the workforce. Less than a decade ago the Angus complex was set for the axe, but has since completed an astonishing turnaround and is in the running for a £500 million investment, as part of plans to build a new biopharmaceutical factory somewhere in the UK. However, the plant at Dungarvan in the Irish county of Waterford was handed a €30 million injection just three years ago and is now making substantial redundancies, leading to speculation at the firm’s other premises.
